Beck S L
Department of Biological Sciences, Depaul University, Chicago, Illinois 60604.
Teratology. 1989 Oct;40(4):365-74. doi: 10.1002/tera.1420400409.
Following exposure to bromodeoxyuridine (BUDR), acetazolamide (ACZM), trypan blue (TRBL), cortisone (CORT), or diphenylhydantoin (DPH), alizarin-stained, cleared fetuses were examined at 18 days postcoitus for unossified cervical vertebral centra; number of ossified caudal vertebrae; number of ribs; and ossification of sternebrae, metatarsals, metacarpals, and phalangeal rows. At all teratogenic doses, in no vehicle-treated groups, and rarely in lower-dose groups, there were significant increases in frequency of unossified cervical centra, the first vertebra (C1) being most often affected, and C7 least often affected. In the high-dose CORT group, there was a significant correlation between unossified C1 and cleft palate. No association between abnormality and reduced ossification of cervical vertebrae was seen in other series examined, nor was there any correlation between litter size and abnormality. With minor complications, the number of ossified caudal vertebrae was significantly reduced after exposure at teratogenic dose levels to all compounds except DPH. Although caudal and cervical ossification were correlated with each other in those series examined, neither was correlated with abnormality. Frequency of 14 ribs was increased in BUDR, ACZM, and TRBL but not CORT or DPH. Other parameters were essentially unaffected. Significantly increased frequency of abnormality, when contrasted with untreated or vehicle-treated groups, was seen at high-dose levels in all but DPH treatments, and mortality was increased in ACZM D9-11, TRBL, and CORT. These studies show that reduced ossification of cervical centra is an excellent indicator of prenatal exposure to noxious substances, and caudal vertebrae appear to be useful as well. Increased frequency of 14 ribs occurred for all strong teratogens utilized if they were administered on day 7 or day 8 postcoitus.
在暴露于溴脱氧尿苷(BUDR)、乙酰唑胺(ACZM)、台盼蓝(TRBL)、可的松(CORT)或苯妥英(DPH)之后,对经茜素染色、透明处理的胎儿在交配后18天进行检查,观察未骨化的颈椎椎体中心、骨化尾椎的数量、肋骨数量以及胸骨节、跖骨、掌骨和指骨排的骨化情况。在所有致畸剂量下,在无载体处理组中未出现,在低剂量组中也很少出现未骨化颈椎中心频率的显著增加,第一颈椎(C1)最常受影响,第七颈椎(C7)最少受影响。在高剂量CORT组中,未骨化的C1与腭裂之间存在显著相关性。在其他检查系列中未发现异常与颈椎骨化减少之间的关联,窝仔数与异常之间也没有相关性。除了一些小并发症外,在致畸剂量水平暴露于除DPH之外的所有化合物后,骨化尾椎的数量显著减少。尽管在这些检查系列中尾椎和颈椎骨化相互相关,但两者均与异常无关。在BUDR、ACZM和TRBL组中14根肋骨的频率增加,但在CORT或DPH组中未增加。其他参数基本未受影响。与未处理或载体处理组相比,除DPH处理外,在所有高剂量组中均观察到异常频率显著增加,并且在ACZM D9 - 11、TRBL和CORT组中死亡率增加。这些研究表明,颈椎中心骨化减少是产前接触有害物质的一个良好指标,尾椎似乎也有用。如果在交配后第7天或第8天给予所有使用的强致畸剂,则14根肋骨的频率会增加。